VentiRx is a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like Receptor 8 (TLR8) immunotherapies for the treatment of cancer, respiratory and inflammatory diseases. VentiRx has a broad clinical pipeline. The lead clinical oncology asset, VTX-2337, is a small molecule TLR8 agonist, currently in multiple clinical trials in combination with chemotherapies and monoclonal antibodies. The company has entered into a worldwide strategic collaboration with Celgene Corporation for this program.
View Top Employees from VentiRx Pharmaceuticals| Website | http://www.ventirx.com/ |
| Employees | 8 (6 on RocketReach) |
| Founded | 2006 |
| Phone | (206) 689-2259 |
| Technologies |
JavaScript,
HTML,
Twitter
+50 more
(view full list)
|
| Industry | Biotechnology, Pharmaceuticals, Science and Engineering, Other Pharmaceuticals and Biotechnology, Health Care, Therapeutics |
Looking for a particular VentiRx Pharmaceuticals employee's phone or email?
VentiRx Pharmaceuticals Questions
6 people are employed at VentiRx Pharmaceuticals.
VentiRx Pharmaceuticals is based in Summit, New Jersey.
Top VentiRx Pharmaceuticals Employees
-
12
-
12
-
-
1
-
ViewBrittany Robertson
Executive Assistant at VentiRx Pharmaceuticals
Seattle, Washington, United States13
Related Companies
